Telehealth strategy to mitigate the negative psychological impact of the COVID-19 pandemic on type 2 diabetes: A randomized controlled trial

Alessi, Janine; Oliveira, Giovana Berger de; Franco, Débora Wilke; Becker, Alice Scalzilli; Knijnik, Carolina Padilla; Kobe, Gabriel Luiz; Amaral, Bibiana; Brito, Ariane de; Schaan, Beatriz D’Agord; Teló, Gabriela Heiden

doi:10.1007/s00592-021-01690-1

Cited by 48 publications

(49 citation statements)

References 25 publications

(36 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Follow-ups with chronic condition patients were the second most reported telemedicine application. Alessi et al ( 28 ) conducted a study in which 91 study participants with a prior diagnosis of type 2 diabetes were followed up via phone consultations lasting 5–10 mins each for 16 weeks. Participants in the study were unable to access outpatient clinics as they were closed due to COVID-19 restrictions.…”

Section: Resultsmentioning

confidence: 99%

Telemedicine in Low- and Middle-Income Countries During the COVID-19 Pandemic: A Scoping Review

Mahmoud

Jaramillo

Barteit

2022

Front. Public Health

View full text Add to dashboard Cite

BackgroundCOVID-19 has impacted the capacity of healthcare systems worldwide, particularly in low- and middle-income countries (LMICs), which are already under strain due to population growth and insufficient resources. Since the COVID-19 pandemic's emergence, there has been an urgent need for a rapid and adequate reaction to the pandemic's disruption of healthcare systems. To this end, telemedicine has been shown in prior research to be a feasible approach. The overarching objective of this scoping review was to determine the extent and acceptance of telemedicine in healthcare in low- and middle-income countries (LMICs) during the COVID-19 pandemic.MethodsThis scoping review followed PRISMA guidelines and Arksey and O'Malley's five-stage framework to identify available evidence. We systematically searched four academic databases for peer-reviewed literature published between January 2020 and April 2021: Medline, PubMed, Web of Science, and Scopus, as well as Google Scholar as a source for grey literature.ResultsThe search identified 54 articles with 45,843 participants, including 6,966 healthcare professionals and 36,877 healthcare users. We identified a range of reasons for introducing telemedicine in LMICs during COVID-19, most notably to maintain non-emergency healthcare, enhance access to healthcare providers, and reduce the risk of infection among health users and providers. Overall, healthcare providers and users have shown a high level of acceptance for telemedicine services. During the COVID-19 pandemic, telemedicine provided access to healthcare in the majority of included articles. Nonetheless, some challenges to accepting telemedicine as a method of healthcare delivery have been reported, including technological, regulatory, and economical challenges.ConclusionTelemedicine was found to improve access to high-quality healthcare and decrease infection risk in LMICs during COVID-19. In general, infrastructure and regulatory barriers found to be the most significant barriers to wider telemedicine use, and should be considered when implementing telemedicine more broadly. There appears to be a need to prioritize patient data safety, as many healthcare practitioners utilized commercial apps and services as telemedicine systems. Additionally, it appears as though there is a need to increase capacity, skill, and transparency, as well as to educate patients about telemedicine.

show abstract

Section: Resultsmentioning

confidence: 99%

Telemedicine in Low- and Middle-Income Countries During the COVID-19 Pandemic: A Scoping Review

Mahmoud

Jaramillo

Barteit

2022

Front. Public Health

View full text Add to dashboard Cite

show abstract

“…These results indicate the importance of developing strategies to mitigate the negative effects on mental health in especially patients with diabetes during the COVID-19 pandemic. One possibility would be to use telecommunication, which has been shown to have the potential to reduce diabetes-related emotional distress [ 75 ]. Thereby, the pandemic has presented people with diabetes and their healthcare providers with an opportunity to innovate and use digitalised care for home support [ 76 ].…”

Section: Interface Between Covid-19 Diabetes and Depressionmentioning

confidence: 99%

The interface of COVID-19, diabetes, and depression

et al. 2022

View full text Add to dashboard Cite

Comorbid diabetes with depression is a challenging and often under-recognized clinical problem. During the current COVID-19 pandemic, a communicable disease is thriving on the increasing incidences of these non-communicable diseases. These three different health problems are bidirectionally connected forming a vicious cycle. Firstly, depressed individuals show a higher risk of developing diabetes and patients with diabetes have a higher risk of developing symptoms of depression. Secondly, patients with diabetes have a higher risk of developing severe COVID-19 as well as of experiencing breakthrough infections. Thirdly, in both patients with type 2 diabetes and in COVID-19 survivors the prevalence of depression seems to be increased. Fourthly, lockdown and quarantine measurements during the COVID-19 pandemic has led to an increase in depression. Therefore, it is of importance to increase the awareness of this interface between depression, diabetes and COVID-19. Finally, as symptoms of post-COVID, diabetes and depression may be overlapping, there is a need for educating skilled personnel in the management of these comorbidities.

show abstract

“…Scheduled appointments between January 1st and November 6th, 2020, were used to assess the impact of the pandemic on quality of care indicators in this population, in comparison with the data collected from the same group of patients in 2019. In Brazil, the rst case of COVID-19 was diagnosed on February 26th, 2020 [11], and, during the pandemic, three main peaks occurred in the months of August 2020, December 2020 and March 2021 in the South region [20]. In March 22nd, 2020, the city of Porto Alegre, where most studied participants reside, presented its rst requirement that guides social distancing and regulates establishments.…”

Section: Study Design and Settingmentioning

confidence: 99%

Quality of Care in Patients with Type 1 Diabetes During the COVID-19 Pandemic: A Cohort Study from Southern Brazil

Foppa

Alessi

Nemetz

et al. 2022

Preprint

Self Cite

View full text Add to dashboard Cite

Background: Optimal glycemic control is the main goal for patients with diabetes. The results of type 1 diabetes patients’ neglected demands during the pandemic can determine a long-term negative clinical, social, and economic impact, and result in worse diabetes control and a higher incidence of chronic complications. Therefore, this study aims to evaluate the impact of the COVID-19 outbreak in the quality of care of patients with type 1 diabetes in Southern Brazil.Methods: Cohort study based on electronic medical records of patients with type 1 diabetes, with scheduled appointments between January 1st 2020, and November 6th 2020, at a university public hospital. The quality indicators used were: assessment of albuminuria and/or serum creatinine, lipid profile, thyroid-stimulating hormone, glycated hemoglobin, retinopathy, and neuropathy. McNemar test was used to analyze categorical variables and the Wilcoxon test for continuous variables.Results: Out of 289 patients, 49.5% were women aged 40 ± 12 years old. During the pandemic, 252 patients had at least one face-to-face appointment canceled. The quality of care indicators showed a significant worsening during the COVID-19 pandemic compared to the previous year (p<0.001). In 2019, 23.2% of the participants had all the indicators evaluated, while in 2020, during the pandemic, only 3.5% had all of them evaluated.Conclusion: The COVID-19 pandemic hindered the offer of comprehensive and quality care to patients with type 1 diabetes.

show abstract

Telehealth strategy to mitigate the negative psychological impact of the COVID-19 pandemic on type 2 diabetes: A randomized controlled trial

Cited by 48 publications

References 25 publications

Telemedicine in Low- and Middle-Income Countries During the COVID-19 Pandemic: A Scoping Review

Telemedicine in Low- and Middle-Income Countries During the COVID-19 Pandemic: A Scoping Review

The interface of COVID-19, diabetes, and depression

Quality of Care in Patients with Type 1 Diabetes During the COVID-19 Pandemic: A Cohort Study from Southern Brazil

Contact Info

Product

Resources

About